Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools GIST

GIST

Programs, trials, and reported response and survival for gastrointestinal stromal tumor.

Data as of 11.07.2026

All studies

Velzatinib (IDRX-42, GSK6042981)

StrateGIST Frontline

GSK · Phase 3 · Recruiting · Enrollment 800

NCT07585266

Catalyst Primary completion. 08.30.2032. ClinicalTrials.gov primary completion date. This is a registry date, not a company readout.

ArmPopulationDoseEstimandComparatorEfficacy

No efficacy figure is in this file for this study.